---
source_image: "deposition-transcript+legal-filing+court-document+scanned-document__EFTA01378975_20260130_p001_i001.png"
source_pdf: "EFTA01378975.pdf"
method: pdf_text
words: 574
confidence: 1.00
extracted: 2026-02-13T16:50:14.614303
---

Additional Terms Specific to the Securities 
You should read this pricing supplement together with the underlying supplement dated April 19, 2018, the product supplement 
dated June 30, 2017, the prospectus supplement dated June 30, 2017 and the prospectus dated June 30, 2017, relating to our 
Medium-Term Notes of which these securities are a part. You may access these documents on the SEC website at 
www.sec.gov as follows (or if such address has changed, by reviewing our filings for the relevant date on the SEC website): 
• 
Underlying Supplement dated April 19, 2018: 
htlps://www.sec.gov/Archives/edgar/data/1053092/000095010318004962/dp89590 424b2-underNinq.htm 
• 
Product Supplement No. I-B dated June 30, 2017: 
http://www.secmov/Archives/edoar/data/1053092/000095010317006316/d077781 424 b2-ib.htm 
• 
Prospectus Supplement and Prospectus dated June 30, 2017: 
http://www.sec.gov/Archives/edqaddata/1053092/000104746917004364/a2232566z424b2.htm 
In the event the terms of the securities described in this pricing supplement differ from, or are inconsistent with, the terms 
described in the underlying supplement, any product supplement, the prospectus supplement or prospectus, the terms 
described in this pricing supplement will control. 
Our Central Index Key, or CIK, on the SEC website is 1053092. As used in this pricing supplement, "we," us," or "our" refers to 
Credit Suisse. 
This pricing supplement, together with the documents listed above, contains the terms of the securities and supersedes all 
other prior or contemporaneous oral statements as well as any other written materials including preliminary or indicative pricing 
terms, fact sheets, correspondence, trade ideas, structures for implementation, sample structures, brochures or other 
educational materials of ours. We may, without the consent of the registered holder of the securities and the owner of any 
beneficial interest in the securities, amend the securities to conform to its terms as set forth in this pricing supplement and the 
documents listed above, and the trustee is authorized to enter into any such amendment without any such consent. You should 
carefully consider, among other things, the matters set forth in 'Selected Risk Considerations" in this pricing supplement and 
'Risk Factors" in any accompanying product supplement, "Foreign Currency Risks" in the accompanying prospectus, and any 
risk factors we describe in the combined Annual Report on Form 20-F of Credit Suisse Group AG and us incorporated by 
reference therein, and any additional risk factors we describe in future filings we make with the SEC under the Securities 
Exchange Act of 1934, as amended, as the securities involve risks not associated with conventional debt securities. You should 
consult your investment, legal, tax, accounting and other advisors before deciding to invest in the securities. 
Prohibition of Sales to EEA Retail Investors 
The securities may not be offered, sold or otherwise made available to any retail investor in the European Economic Area. For 
the purposes of this provision: 
(a) the expression "retail investor" means a person who is one (or more) of the following: 
(i) a retail client as defined in point (11) of Article 4(1) of Directive 2014/65/EU (as amended, "MiFID II"); or 
(i) a customer within the meaning of Directive 2002/92/EC, where that customer would not qualify as a professional client 
as defined in point (10) of Article 4(1) of MiFID II; or 
(ii) not a qualified investor as defined in Directive 2003/71/EC; and 
(b) the expression "offer" includes the communication in any form and by any means of sufficient information on the terms of 
the offer and the securities offered so as to enable an investor to decide to purchase or subscribe the securities. 
3 
CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) 
DB-SDNY-0076258 
CONFIDENTIAL 
SDNY_GM_00222442 
EFTA01378975
